Teleflex gains after revenue growth, profit forecast raise

Shares of surgical-equipment maker Teleflex TFX.N rise 14.2% to $130.03 premarket

Company raises its full-year adjusted revenue growth outlook from between 1% and 2% to 7.70% to 8.70%, reflecting the acquisition of the BIOTRONIK's Vascular Intervention business

Adds acquisition is expected to generate revenues of $204 million in H2 2025

Also raises its 2025 adjusted profit per share outlook from a $13.20 to $13.60 range to $13.90 to $14.30

Analysts had expected a profit of $13.37 per share

For the quarter, company reported adjusted profit of $3.73 versus estimate of $3.36

Up to last close, stock down 36% YTD